Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP2 | P42575 | 1/20 | 0.60 |
| ▸ | NAAA | Q02083 | 1/20 | 0.56 |
| ▸ | EPHX1 | P07099 | 9/20 | 0.55 |
| ▸ | FAAH | O00519 | 2/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.47 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5907656 | 1.00 | CASP2 (0.60) | CASP2NAAAEPHX1FAAHMEN1 | |
| SCHEMBL8880540 | 1.00 | CASP2 (0.60) | CASP2NAAAEPHX1FAAHMEN1 | |
| SCHEMBL5907662 | 1.00 | CASP2 (0.60) | CASP2NAAAEPHX1FAAHMEN1 | |
| SCHEMBL5907670 | 1.00 | CASP2 (0.60) | CASP2NAAAEPHX1FAAHMEN1 | |
| SCHEMBL5907644 | 1.00 | CASP2 (0.60) | CASP2NAAAEPHX1FAAHMEN1 | |
| SCHEMBL5907631 | 1.00 | CASP2 (0.60) | CASP2NAAAEPHX1FAAHMEN1 | |
| SCHEMBL5907675 | 1.00 | CASP2 (0.60) | CASP2NAAAEPHX1FAAHMEN1 | |
| SCHEMBL5907687 | 0.98 | CASP2 (0.57) | CASP2NAAAEPHX1FAAHMEN1 | |
| SCHEMBL5907669 | 0.92 | CASP2 (0.48) | CASP2NAAAEPHX1FAAHMEN1 | |
| SCHEMBL14984047 | 0.92 | ALDH1A1 (0.50) | CASP2NAAAEPHX1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060046286-A1 | Method for preparing optically active beta-butyrolactones | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2006-03-02 | — | — | US | disclosed |